This compound was tested also in combination with cisplatin on tumor spheroids isolated from primary tumors: spheroids resistant to these two drugs have the tendency to the loss of CD133 expression and a decrease of ALDH activity [222]. This evidence concerns the gene PROM1 and neoplasm.